Delivery Order SPE2DB22D1106-SPE2DB24FFBM7

Award Date 7/11/24
Potential Completion Date 7/12/24
Potential Value $5.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a contract award to AmerisourceBergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor, by the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $37,411 firm-fixed-price delivery order is for the supply of the HIV medication Biktarvy 50-200-25 mg tablets. The contract has an ultimate completion date of September 30, 2024. AmerisourceBergen holds a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical valued...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of the HIV medication Biktarvy 50-200-25 mg tablet. The $26,557.84 firm fixed-price delivery order has a completion date of July 24, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,922.18 firm fixed-price delivery order is for the medication Biktarvy, a treatment for HIV. The contract has a completion date of December 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $57,385.59 firm fixed-price delivery order is for the supply of the HIV medication Biktarvy, with an ultimate completion date of January 18, 2024. This contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,035.68 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a medication used to treat HIV infection. The contract has an ultimate completion date of November 1, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the HIV medication Biktarvy 50-200-25 mg tablets. The award, valued at $31,523.82, is a firm fixed-price delivery order placed by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of December 5, 2024 and was awarded on December 4, 2024. There is no set-aside designation indicated for this contract. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,287.95 firm fixed-price delivery order is for the supply of the HIV medication Biktarvy, with a completion date of November 5, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $12,960.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Biktarvy 50-200-25 mg tablets, a specialty medication used for HIV treatment. The contract is a firm fixed-price Delivery Order with an ultimate completion date of April 22, 2024. This award is not associated with a set-aside designation, indicating open...
This is a $22,807.04 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of the HIV medication Biktarvy 50-200-25 mg tablet, and has a completion date of February 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $18,961.41 firm fixed-price delivery order is for the supply of Biktarvy 50-200-25 mg tablets. The contract has an ultimate completion date of October 8, 2024 and does not utilize a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFBM7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $5,934.84 firm fixed-price delivery order is for the supply of the HIV medication Biktarvy 50-200-25 mg tablets. The contract has an ultimate completion date of July 12, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award was not set aside for any particular business type.

Generated 10/10/24, 9:23 AM